iPS Cells
Ensuring iPSC Quality: Best Practices in Pluripotency Testing for Disease Models
Updated on June 12, 2026 As iPSC disease models become increasingly sophisticated through CRISPR genome editing, organoid development, and...
Read More
Disease Models |
iPS Cells |
Immortalized Cell Lines
Not Your Average Knockout: Introducing Cell Editing with XDel CRISPR Technology
With years of experience and hundreds of thousands of successful edits, this journey has given us invaluable insights into one of the biggest...
Read More
Disease Models |
iPS Cells |
Editing Process
Advancements in Karyotyping & the Impact on Cell-based Research
Last Updated: Jan 28, 2026 Disease modeling using human pluripotent stem cells (hPSCs) has been crucial in drug discovery, and clinical applications....
Read More